Comment on 'Pharmacokinetic interaction between cyclosporine and the dihydropyridine calcium antagonist felodipine' [2]

European Journal of Clinical Pharmacology

Volumn 52, Issue 2, 1997, Pages 159-

  Yeleswaram, K ^a   Madsen, J K ^a   Jensen, J D ^a   Jensen, L W ^a   Pedersen, E B ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ANTAGONIST; CYCLOSPORIN; CYTOCHROME P450; DIHYDROPYRIDINE DERIVATIVE; DOXORUBICIN; DRUG METABOLITE; ETOPOSIDE; FELODIPINE; GLYCOPROTEIN P; NIFEDIPINE;

CANCER RESEARCH; DRUG ABSORPTION; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG METABOLISM; DRUG MIXTURE; DRUG RESEARCH; INTESTINE; LETTER; LIVER; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

EID: 0030998226     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050267     Document Type: Letter

References (7)